AI biology verification startup raises $20M seed led by Quiet Capital, ex-DeepMind researcher joins as co-founder
vqctran · x · 2026-09-17
A startup building the "verification layer" for AI-driven biology announced a $20M seed round led by Quiet Capital, with participation from Gradient, Haystack VC, Compound VC and others.
The thesis: AI is rapidly generating biological hypotheses, therapeutic candidates and experimental designs, but our ability to test them in living human biology lags far behind — existing options force a tradeoff between biological relevance and speed/cost. The company aims to build a scalable environment where models can test predictions against living human biology. Vqctran, formerly of Google DeepMind, has joined as a co-founder.
More from Venture
- Doctors wait up to a year to start: PE-backed staffing firm's Excel-bound credentialing process laid bare — alex_verem · 2026-11-02
- Ad creative automation startup Fastlane launches 2.0 with $3.5M seed round — Shruti_0810 · 2026-11-02
- Toby Walsh predicts market turbulence may force Anthropic to delay its late-2026 IPO — TobyWalsh · 2026-11-02
- Indie dev shuts down 6 zombie apps in one day to cut costs — CtrlAltDwayne · 2026-11-02
- US Black Friday online sales top $11.8B; Cyber Week hits $336.6B globally — ThePeterMick · 2026-11-02
- Alibaba Qwen exec sells AI token credits in Li Jiaqi's livestream targeting women — yangyi · 2026-11-02